The antibody-induced blocking of AGR2 in pancreatic ductal adenocarcinoma cell lines revealed a significantly reduced tumor growth and metastasis and led to tumor regression and improved survival [110]. This evidence concerns the gene AGR2 and pancreatic ductal adenocarcinoma.